Here are six observations:
1. The plastic segment leads the market in terms of material, expected to reach $984.7 million by 2026.
2. In terms of application, the orthopedic implants segment possessed the highest revenue share in the market. It will grow at a CAGR of 19.9 percent through 2026, reaching $643.5 million.
3. Based on distribution, the hospital end-user segment will witness a high demand for 3-D printed medical devices, growing at a CAGR of 18.7 percent through 2026.
4. In 2015, the North American market was valued at $105 million.
5. Western Europe revenues will likely grow at a CAGR of 18.5 percent through 2026, with eastern Europe revenues growing at a CAGR of 15.6 percent.
6. Rock Hill, S.C.-based 3D Systems; Sweden-based Arcam; Eden Prairie, Minn.-based Stratasys; London, U.K.-based FabRx; Krailling, Germany-based EOS GmbH Electro Optical Systems; Gladbeck, Germany-based EnvisionTEC; Tokyo, Japan-based Cyfuse Biomedical K.K.; and Singapore-based Bio3D Technologies lead the market.
More articles on devices:
Stryker 2016 net sales hit $11.3B, up 13.9%: 5 key notes
Amendia names Gary Maingot new EVP of operations: 4 key points
Rhode Island Hospital joins INSPIRE study as 29th clinical site: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
